Valuation: Ningbo Menovo Pharmaceutical Co., Ltd.

Market Cap 8.64B 1.29B 1.11B 1.05B 952M 1.79B 123B 1.8B 12.48B 4.8B 62.6B 4.84B 4.73B 198B P/E 2024
41x
P/E 2025 40.9x
Enterprise Value 9.23B 1.38B 1.18B 1.12B 1.02B 1.91B 131B 1.92B 13.32B 5.12B 66.84B 5.16B 5.05B 211B EV / Sales 2024
2.46x
EV / Sales 2025 3.21x
Free-Float
70.49%
Yield 2024
0.39%
Yield 2025 0.81%
1 day-3.93%
1 week-6.95%
Current month-3.89%
1 month-21.95%
3 months-7.32%
6 months+40.28%
Current year+84.97%
1 week 25.08
Extreme 25.08
28.4
1 month 25.08
Extreme 25.08
32.67
Current year 13.71
Extreme 13.714285
50.28
1 year 13.55
Extreme 13.549999
50.28
3 years 7.11
Extreme 7.114285
50.28
5 years 7.11
Extreme 7.114285
50.28
10 years 6.9
Extreme 6.902446
50.28
Manager TitleAgeSince
Chief Executive Officer 52 2004-02-18
Director of Finance/CFO 55 2021-05-11
Investor Relations Contact 39 -
Director TitleAgeSince
Chairman 52 2004-02-18
Chairman 37 2021-05-11
Director/Board Member 55 2021-05-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/22 Sell

Director

44,300 0.0210%
11/14/22 Sell 13,500 0.0064%
7/12/22 Buy

Chief Executive Officer

3,430,253 1.6290%
Change 5-day change 1-year change 3-year change Capi.($)
-3.93%-6.95%+45.32%+115.16% 1.29B
-0.65%-2.93%+47.70%+86.30% 994B
-0.29%-3.51%+49.15%+61.95% 640B
+0.83%+0.26%+17.76%+70.10% 454B
+3.62%+0.71%+36.75%+37.20% 337B
+2.34%-8.72%+17.26%+25.53% 261B
+2.20%-0.77%+4.80%+10.62% 246B
-1.34%-13.70%+36.53%+46.70% 204B
+1.56%-6.07%-20.92%-58.88% 190B
-0.75%-4.82%+25.46%+85.90% 178B
Average +0.36%-5.92%+25.98%+48.06% 350.61B
Weighted average by Cap. +0.51%-4.42%+32.26%+55.03%

Financials

2024 2025
Net sales 1.37B 205M 176M 167M 151M 284M 19.55B 285M 1.98B 762M 9.95B 769M 752M 31.43B 1.5B 224M 193M 183M 166M 311M 21.41B 312M 2.17B 835M 10.89B 841M 823M 34.41B
Net income 66.81M 9.96M 8.58M 8.12M 7.36M 13.81M 951M 13.88M 96.49M 37.1M 484M 37.4M 36.58M 1.53B 102M 15.24M 13.13M 12.43M 11.27M 21.14M 1.46B 21.25M 148M 56.78M 741M 57.23M 55.97M 2.34B
Net Debt 602M 89.68M 77.27M 73.17M 66.32M 124M 8.57B 125M 869M 334M 4.36B 337M 329M 13.77B 584M 87.09M 75.04M 71.05M 64.4M 121M 8.32B 121M 844M 324M 4.23B 327M 320M 13.38B
Logo Ningbo Menovo Pharmaceutical Co., Ltd.
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations. The Company is mainly engaged in three businesses. The contract development and manufacturing organization (CDMO) business mainly provides pharmaceutical companies with CDMO services for the entire preparation industry chain. The specialty API business is mainly engaged in the production and sales of APIs. The preparation business is mainly engaged in the production and sales of preparations. The Company's main products include valsartan, losartan, perindopril, rosuvastatin calcium, atorvastatin calcium and pregabalin. The Company's products are mainly used in cardiovascular, central nervous, antiviral, hypoglycemic, gastrointestinal and other therapeutic areas. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
2,370
Date Price Change Volume
26-09-11 CN¥25.42 -3.93% 27,367,576
26-09-10 CN¥26.46 -2.72% 29,124,900
26-09-09 CN¥27.20 -3.10% 39,737,969
26-09-08 CN¥28.07 +2.22% 47,247,540
26-09-07 CN¥27.46 +0.51% 33,939,021

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603538 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!